Implementation Project

Three NHS hospitals have implemented the new technique into their clinical practice with the aim of improving the quality of care for surgical patients.

Below you can access the learning gathered from the anesthetists, surgeons, nurses and managers who have worked on this technology implementation project. In addition there are support tools and resources for you to download, adapt and use.

To explore this section and view information relevant and useful to you and your organisation please click on the headings below:

Project Background

Three NHS hospitals across England implemented Doppler guided intraoperative fluid management into their routine clinical practice with the aim of improving surgical outcomes and reducing hospital stay for patients undergoing major surgery.

Following a structured implementation programme, patient outcomes were measured in 1200 patients consisting of intervention and control groups of patients, the control group consisting of historical cases undertaken in the year prior to the project start date.

The benefits and barriers and impact of implementation on the use of NHS resources was assessed for each patient care episode by measuring and comparing hospital stay, the use of invasive central venous monitoring catheters (CVC), reoperation and readmission rates.

Project Sites

Central Manchester Hospitals NHS Foundation Trust (CMFT)

Clinical Implementation Lead - Dr Dan Conway, Consultant Anaesthetist

nhs__1262880777_MRI

Manchester Royal Infirmary is multi-speciality, tertiary teaching hospital for Manchester University's Medical School. It is the regional centre for encapsulating peritoneal sclerosis, kidney and pancreas transplant surgery. There is a major vascular surgery programme. Recent developments in service across the Trust have resulted in an increase in upper GI, hepatic, gynaecological and urological cancer surgery. CMFT is an inner city tertiary teaching hospital and treats patients with complex co-morbidities and complex surgical procedures. On January 1st 2009, CMFT became a foundation Trust and currently employs over 8000 staff. Over 94,000 operations are performed each year and approximately 2000 of these operations are major surgical procedures.

As part of the implementation project, anaesthetic consultants volunteered to 'champion' the technology in a range of surgical specialities. Following classroom and in-theatre training provided by the supplier and peers, the champions initiated the audit with the following conditions:

  1. Oesophageal Doppler monitoring will guide intra-operative fluid replacement to optimise stroke volume in appropriate cases according to strict criteria and protocol agreed by the group.
  2. Data should be collected with 100% compliance by the consultant champions

Oesophageal Doppler guided intraoperative fluid management has been successfully implemented in the following surgical areas: urology, vascular, upper gastro intestinal cancer, emergency, colorectal, orthopaedics and transplantation.

Patient outcomes were measured in patients consisting of intervention and comparator groups of patients, the comparator group consisting of historical cases undertaken in the year prior to the project implementation start date of January 2009.To minimise bias, both groups were closely matched according to specialist surgical team and OPCS code.

In comparison to the other project sites, Manchester has implemented the Doppler technology in a range of emergency and scheduled surgical procedures as well as elective and planned cases. These factors have contributed to Manchester observing a higher pre-operative risk score (POSSUM) in both the intervention and comparator groups.

Derby Hospitals NHS Foundation Trust

Clinical Implementation Lead - Dr Stuart Gold, Consultant Anaesthetist

nhs__1262880744_derby

The Royal Derby Hospital is a £334 million new hospital providing a wide range of services including general medical, surgical, maternity, rehabilitation care and accident and emergency services, With a total of 1,187 beds and 35 operating theatres, the Trust serves a population of over 600,000 people in and around southern Derbyshire.

As part of the implementation project we chose to focus on implementation of oesophageal Doppler guided intraoperative fluid management in elective colorectal surgery, This service had already been moved to the new hospital site and it was possible to concentrate our project on this patient group. Elective colorectal surgery also has the greatest body of evidence supporting the use of the oesophageal Doppler monitor for fluid optimisation.

Following classroom and in-theatre training we encouraged anaesthetists to use oesophageal Doppler monitoring for all colorectal resections.

Our project implementation start date was the 18th September 2008. We have collected data from all colorectal procedures carried out following the start of our project; this data has been compared to the previous years colorectal surgical cases. All data has been collected prospectively by one of 2 audit facilitators. We have subjected our data to quality assurance assessment through systematic examination of our data which verified the accuracy of our clinical data.

Whittington NHS Trust

Clinical implementation Lead - Dr Martin Kuper, Consultant Anaethetist

nhs__1262880797_whittington

The Whittington is an acute general hospital in Archway, North London, which serves a diverse local population of approximately 250,000 and has 467 inpatient beds. The Whittington is one of the teaching hospitals for University College London.

At the Whittington, the Doppler project implementation went live on 1st April 2008 and project data collection completed on 30th April 2009. We aimed to collect data on at least 200 patients undergoing orthopaedic and colorectal surgery. In orthopaedic surgery we recruited patients undergoing urgent repair of neck of femur fracture and elective total hip replacement. In colorectal surgery we recruited patients undergoing emergency or elective bowel resection, excluding simple appendicectomy and small bowel perforation. Approximately equal numbers of retrospective comparators, matched for speciality and urgency, were drawn from patients who had met the same operative criteria during the preceding year i.e. 1st March 2007-31st March 2008.

Change Rationale

About 3 million operations are carried out in the UK every year, with a hospital mortality rate of 0.8-1.0 %. Over 20,000 patients die a year following surgery and there are concerns that UK may have significantly higher mortality rates compared with the health care systems in comparable countries.

Optimal management of cardiac output, fluid balance and haemodynamic status is considered to be a key factor in improving the outcomes of high risk surgery and critically ill patients.

Using cardiac output monitoring to guide fluid replacement and pharmacological treatment allows haemodynamic status to be optimised, and thus helping to maintain adequate blood supplies to the tissues. Monitoring therefore, offers the potential to reduce mortality, complication rates, length of stay in critical care facilities and overall hospital stay, all of which offer significant potential to reduce healthcare costs

In 2007 the Improving Surgical Outcomes Group , an independent medical group comprising surgeons, anaesthetists, critical care consultants and others involved in operative management and care published a report "Modernising Care for Patients Undergoing Major Surgery". This report highlighted a number of clinically proventechniques and technologies that improve outcomes for patients stating that "haemodynamic optimisation and other interventions significantly reduce both the rates of post-operative complications and mortality, as well as significantly reducing both the length of hospital stay and the overall number of ICU / HDU bed days used."

Despite a comprehensive evidence base comprising of eight randomised controlled trials demonstrating significantly improvements in surgical outcomes, uptake of this technology has been poor across the NHS. In late 2007 this technology was selected by the NHS Technology Adoption Centre as one of its first implementation projects in which it set out to understand and overcome the barriers to widespread adoption of this technique by working with clinicians and managers throughout the implementation process with 3 NHS organisations in England

Each organisation implemented Doppler guided intraoperative fluid management into routine clinical and operational practice representative of NHS practice and assessed the impact on patient outcomes and the use of resources compared to historical standards of care.

Project Outcome Measures

The impact of implementation was measured by assessing the peri-operative morbidity and mortality risk, intraoperative audit and post operative morbidity assessment

Perioperative Risk Evaluation

The POSSUM peri-operative risk evaluation scoring system was utilised to assess patient morbidity and mortality risk and to record operative severity. With the variety of surgical procedures undertaken as part of the audit, it was important to use a scoring system which would be applicable across the surgical spectrum as well as in elective and emergency settings.

POSSUM has been validated in the UK across a wide spectrum of surgical procedures for both research and clinical audit and most centres have experience with its use.

Intraoperative Audit

An electronic audit form was developed to record details of the intervention including the methods of haemodynamic monitoring used, cardiac output measurements recorded, intra-operative fluids administered and any related complications recorded during surgery.

Postoperative Evaluation of Morbidity

POMS is the only published prospective method for describing short term morbidity after surgery and was designed to identify morbidity of a type and severity that would delay discharge from hospital . Measurement focuses on easily collectable indications of clinically important dysfunction in key organ systems. Indicators were available from routinely available sources and did not require special or additional investigations.

In addition mortality rates were recorded for the intervention and comparator groups

Use of NHS Resources

The impact of implementation on resources was evaluated by measuring:

  • Admissions and length of stay in critical care
  • Overall length of hospital stay
  • Rates of readmission and reoperation
  • The use of invasive monitoring techniques (central venous catheters)

Achieving Change

Controlled implementation was undertaken at 3 hospital sites in England representing a broad spectrum of clinical practice Intervention with Doppler guided fluid management was continuously audited throughout the project period. Data was collected via a secure web based database. Performance reports were generated monthly for each of the participating sites.

Project teams were established at each of the implementation sites consisting of:

Clinical Implementation Project Lead - Consultant Anesthetist with responsibility for clinical leadership, directing education and in-theatre training programmes, guideline and protocol development for intra-operative fluid management (IOFM), clinical liaison with local clinical champions including troubleshooting , identifying and overcoming barriers and promoting the implementation pathway.

Clinical Audit Facilitator. Responsibility for the development and implementation of audit tools, data collection and the management of the online database. Liaison with local trust clinical and administration staff teams, education, troubleshooting and quality assurance, compliance with data collection requirements, monthly reporting to Trust management team.

General Manager: Responsibility for the local management of the overall project including the development of project plans, terms of reference, schedules of work, Responsible for ensuring a systematic approach to implementation is taken including the development of a robust business case, informatics support and the provision of adequate resources for sustainable implementation.

Clinical Champion: Responsible for leading clinical implementation, a number of core activities, including education, advocacy, relationship building and boundary spanning. The clinical champion role is a concept that has been widely promoted yet empirically underdeveloped in the NHS. In this project the Clinical Champion was central to the success of implementation.

For further information on the role of clinical champions Click Here

Impact Evaluation

Methods and procedures of quantitative, qualitative and periodical measurement and evaluation of Doppler guided intraoperative fluid management were developed by the project teams from the three implementation sites. These were used in the determination of the impact of the intervention on patient outcomes and hospital productivity.

The metrics were applied across a range of specified surgical specialties that were subject to assessment and audit and where training had been undertaken and competency assessed. This was to ensure that data integrity was always assured, thereby reducing the risk that the metrics may be tampered or modified when used for a different process.

The metrics themselves were developed by multidisciplinary teams from all 3 project sites who identified appropriate evidence based measurement and evaluation techniques.

These metrics formed the basis for the development of a secure online database consisting of 3 data collection forms in order to collect all the necessary data for comprehensive metrics analysis:

  • Pre-operative morbidity assessment
  • Intra-operative procedural audit
  • Post operative morbidity assessment

These metrics were then organised and classified into specialty categories and the following performance aspects were measured during the project.

  • Urgency of surgery
  • Length of hospital stay
  • Rates of readmission and reoperation
  • Use of invasive monitoring techniques
  • Post -operative morbidity and mortality
  • Admissions and length of stay in critical care

These evaluation measures and values were subjected to independent statistical analysis undertaken by York Health Economics Consortium at York University.

Click here to access the project summary data

Measurements of Success

The primary task of this project is to improve patient outcomes following major surgery.

A fundamental goal within this was to measure the impact of this technique and identify the potential benefits, costs and practical issues associated with the routine implementation of Doppler guided intraoperative fluid management.

We undertook the following measurements to assess patient outcomes and impact on productivity and the use of resources so that we could provide relevant information to help providers and commissioners make informed choices about how the adoption of this technique could make a positive difference to NHS performance and the well being of patients.

  • Post operative morbidity and mortality
  • Admission rates to critical care
  • Length of critical care and overall hospital stay
  • Readmission and reoperation rates
  • The use of central venous monitoring catheters (CVC)
  • Critical Care length of stay

Click here to access the implementation project summary data

Welcome to the How To Why To Guide

The NHS Technology Adoption Centre How To Why To Guides. They are designed to provide you with information about innovative medical technologies, the benefits and barriers to adoption along with practical implementation tools for your organisation.

Please agree to the terms and conditions below before entering the site.

1. Agreement

1.1 This freely accessible version of the How To Why To Guide is a generalised assessment version of a select number of Technology Implementation Projects undertaken by the NHS Technology Adoption Centre ("NTAC) that has been provided to allow you to see how adoption processes operates (the ´Guides´). The Guides are produced and made available by The NHS Technology Adoption Centre. By accessing the Guides you ("you") agree to these Terms.

1.2 These Terms form the agreement between you and us. If you do not agree to be legally bound by these Terms please leave this section of the website immediately. Your continued access and use of the website and/or the How To Why To Guide will amount to acceptance.

1.3 You are hereby granted a non-transferable, non-exclusive licence to view the Guides for your personal assessment and non-commercial purposes until your access is terminated by us.

2. Disclaimer

2.1 Liability

2.1.1 Neither NTAC, nor its contributors shall be held liable for any improper or incorrect use of the information described and/or contained on this site and NTAC assumes no responsibility for anyone´s use of the information.

2.1.2 In no event shall NTAC, or contributors be liable for any direct, indirect, incidental, special, exemplary, or consequential damages (including, but not limited to, procurement or substitute goods or services; loss of use, data, or profits; or business interruption) however caused and on any theory of liability, whether in contract, strict liability, or tort (including negligence or otherwise) arising in any way out of the use of this site or system.

2.1.3 This disclaimer of liability applies to any damages or injury, including but not limited to those caused by any failure of performance, error, omission, interruption, deletion, defect, delay in operation or transmission, computer virus, communication line failure, theft or destruction or unauthorized access to, alteration of, or use of record, whether for breach of contract, tortuous behaviour, negligence or under any other cause of action.

2.2 Warranties/Accuracy of Information

2.2.1 Although the data found using the NTAC site has been produced and processed from sources believed to be reliable, no warranty expressed or implied is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information.

2.2.2 This disclaimer applies to both isolated and aggregate uses of the information. NTAC provides this information on an "as is" basis. All warranties of any kind express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses and non-infringement of proprietary rights ARE DISCLAIMED.

2.2.3 Changes may be periodically added to the information contained in our "How to why to guides "; these changes may or may not be incorporated in any new version of the guide. If you have obtained information on the NTAC site from a source other than NTAC, please be aware that electronic data can be altered subsequent to original distribution. Data can also quickly become out-of-date.

2.3 Endorsement

2.3.1 NTAC is a distributor of content sometimes supplied by third parties and users. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by third parties, including information providers, users, or others, are those of the respective author(s) or distributor(s) and do not necessarily state or reflect those of NTAC and shall not be used for advertising or product endorsement purposes.

2.3.2 Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favouring by NTAC.

2.4 Duty to Continue Provision of "How to why to Guides"

2.4.1 Due to the dynamic nature of the Internet, resources that are publicly available one day may require restriction of access the next, and the location of items may change as menus, homepages, and files are reorganised.

2.4.2 User expressly agrees that use of NTAC site is at the user's sole risk. Neither NTAC, any entity jointly created by them, each of their affiliates nor any of their respective employees, agency, third party content providers or licenser warrant that the service will be uninterrupted or error free.

2.5 Conflicts of Interest

2.5.1 Neither NTAC, nor its contributors, have received any corporate sponsorship nor hold any financial interest in the companies manufacturing technologies described in our How to why to Guides.

3. Restrictions and intellectual property rights

3.1 The How To Why To Guide contains copyright material, trade names and marks and other proprietary information, including, but not limited to, text, software, photos and graphics ("Content"). The Content is protected by copyright law, database rights and other intellectual property rights.

3.2 The information contained here may not be converted into any other format, or transmitted in any other way, without the consent of the authors. While we encourage hyper-links to be made to this site from other parts of the Web, the pages cannot be copied and saved onto other Web servers in order to be transmitted from those servers, without permission from NTAC. This prohibition applies to those who intend to make copies of this information to retransmit as part of other Web sites; it does not apply to other Web servers which store pages for routine caching purposes.

3.3 In the event of any authorised copying, redistribution or publication of copyright material, no changes in or deletion of author attribution, trademark legend or copyright notice shall be made. You acknowledge that you do not acquire any ownership rights by downloading copyright material.

4. Limitation of liability / indemnity

You agree to defend, indemnify, and hold harmless, NTAC, its contributors, any entity jointly created by them, their respective affiliates and their respective directors, officers, employees, and agents from and against all claims and expenses, including legal fees, arising out of the use of this site or service by user or user's account.

5. External links

5.1 Every effort is made to ensure that access to the How To Why To Guide is uninterrupted and that transmissions will be error-free. However, we cannot, due to the nature of the internet, guarantee that your access will not be suspended from time to time including to allow for repairs, maintenance or the introduction of new content or facilities.

5.2 NTAC, nor its contributors are responsible for the contents of any off-site pages referenced. The user specifically acknowledges that neither NTAC or its contributors is liable for the defamatory, offensive, or illegal conduct of other users, links, or third parties and that the risk of injury from the foregoing rests entirely with the user.

5.3 The How To Why To Guide contains links including hyperlinks which may take you outside of http://www.technologyadoptioncentre.nhs.uk/how-to-why-to-guides.html. Links are provided for your convenience, and an inclusion of any link does not imply endorsement or approval by us of the linked website, its operator or content. These links are provided as an information service only. It is the responsibility to the web surfer to evaluate the content and usefulness of information obtained from other sites.

6. Governing law

6.1 These Terms are governed by English law notwithstanding the jurisdiction where you are based. You irrevocably agree that the courts of England shall have exclusive jurisdiction to settle any dispute which may arise out of, under, or in connection with these Terms and for those purposes irrevocably submit all disputes to the jurisdiction of the English courts. The place of performance shall be England.

6.2 We provide no warranty or guarantee that the Website or information available on it complies with laws other than those of England.

6.3 If any provision (or part) of this agreement is found by any court of competent jurisdiction or administrative body to be invalid, unenforceable or illegal, the other provisions shall remain in force.

7. Further information

7.1 Further information or any queries on them can be obtained from NHS Technology Adoption Centre


I agree to the terms & conditions